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Abstract
Disturbances in tonicity (effective osmolarity) are the major clinical disorders affecting cell
volume. Cell shrinking secondary to hypertonicity causes severe clinical manifestations and
even death. Quantitative management of hypertonic disorders is based on formulas computing
the volume of hypotonic fluids required to correct a given level of hypertonicity. These
formulas have limitations. The major limitation of the predictive formulas is that they
represent closed system calculations and have been tested in anuric animals. Consequently,
the formulas do not account for ongoing fluid losses during development or treatment of the
hypertonic disorders. In addition, early comparisons of serum osmolality changes predicted by
these formulas and observed in animals infused with hypertonic solutions clearly demonstrated
that hypertonicity creates new intracellular solutes causing rises in serum osmolality higher
than those predicted by the formulas. The mechanisms and types of intracellular solutes
generated by hypertonicity and the effects of the solutes have been studied extensively in
recent times. The solutes accumulated intracellularly in hypertonic states have potentially
major adverse effects on the outcomes of treatment of these states. When hypertonicity was
produced by the infusion of hypertonic sodium chloride solutions, the predicted and observed
changes in serum sodium concentration were equal. This finding justifies the use of the
predictive formulas in the management of hypernatremic states.
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Introduction And Background
Maintenance of constant volume is of great importance for proper function and survival of body
cells [1]. The regulation of cell volume under normal conditions is the consequence of two
properties of cells, their ability to extrude solute into the extracellular compartment (EC), and
the high permeability of the cellular membranes to water. The main mechanisms of change in
cell volume are disturbances in body fluid tonicity (effective osmolality). Tonicity is the
property of a solution to make cells suspended in it swell by gaining water (hypotonicity) or
shrink by losing water (hypertonicity) through osmotic pressure differences between the
intracellular compartment (IC) and the solution tested. Solutions are isotonic when the volume
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of cells suspended in them does not change by osmotic fluid transfers. Disturbances in tonicity
have clinical consequences. The brain is the site of the principal clinical manifestations of both
hypotonicity and hypertonicity. The neurological manifestations of either hypotonicity or
hypertonicity may lead to irreparable deficits or death. Consequently, proper management of
disturbances in tonicity is critical and requires an understanding of the qualitative and
quantitative aspects of their pathophysiologic mechanisms.
The purpose of this review is to explore the evolution of the quantitative and qualitative
aspects of the concept of hypertonicity and to summarize the experimental work, which has led
to the current understanding of this topic.

Review
Physicochemistry
Definitions of Osmosis, Osmotic Pressure, Osmolality, Osmolarity and Tonicity
Water transfers from or into the cells and, therefore, changes in cell volume are secondary to
osmotic pressure differences between the IC and the EC. Osmosis is the net movement of water
across a selectively permeable (semipermeable) membrane caused by water concentration
difference. Cell membranes are highly permeable to water, less permeable to electrolytes, and
essentially impermeable to large organic polyanions. In a system of two compartments
separated by a semipermeable membrane, osmotic pressure is measured by the hydrostatic
pressure that is needed on the side of the higher solute concentration to stop net osmotic water
movement across the membrane. Osmotic pressure ( ) is mathematically expressed by van’t
Hoff’s law as follows:
{1}
where C is the concentration of solutes in Osm/L, R is the ideal gas constant which is equal to
62.36 L×tor/(mol×K), and T is the absolute temperature in degrees Kelvin (K = 273 + actual
temperature in centigrade degrees). If body temperature is considered constant at 37o
centigrade, then both T (310o Kelvin) and R (and consequently, the product R × T) are constant
and osmotic pressure is a linear function of the osmolar concentration of body fluids. In clinical
practice, osmolar concentration is expressed as osmolality (mOsm/kg water in the solution) or
osmolarity (mOsm/L of the solution). Osmolality provides an accurate measurement of solute
concentration in biological fluids. Osmolarity is less accurate than osmolality because it is
affected by the water content of the solution (the fraction of the volume of the solution that is
water). Differences between osmolality and osmolarity are encountered in serum
measurements. Osmotically active solutes are found only in the water phase of the serum. The
average water content of the serum is 0.93 under normal conditions of hydration and serum
solids. Therefore, serum osmolality exceeds serum osmolarity by approximately 7% under
normal conditions. Serum osmolarity underestimates the true solute concentration in water in
clinical states causing an elevation of serum solid content (e.g., hyperproteinemia,
hyperlipidemia). In this case, the difference between serum osmolality and osmolarity exceeds
7%. This discrepancy is the cause of diagnostic difficulties.
The relationship between osmotic pressure, expressed in mm Hg, and osmolality, expressed in
mOsm/kg, for a solution with an osmolar concentration of 1 Osm/kg can be calculated as
follows: = 62.36 × 310 = 19,332 mm Hg, or (at first approximation) = 19.3 mm Hg for each
mOsm/kg. A dilute solution of a completely dissociated monovalent salt, such as sodium
chloride, will provide two dissolved particles per molecule. Because of interionic attraction
forces, ions do not behave as entirely independent particles in biological fluids. Correction for
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this apparent deviation from van’t Hoff’s law is achieved by using an empirical factor, the
osmotic coefficient, which is considered to be equal to 0.93 for monovalent sodium salts in
solutions with sodium concentration equal or close to the normal serum sodium
concentration. For example, isotonic saline (0.9% or 154 mmol/L sodium chloride in water)
with a water content of almost 100% would have a theoretical osmolality of 308 (154 sodium +
154 chloride) mOsm/kg. Its actual osmolality is 0.93 × 308 = 286 mOsm/kg. Serum osmolarity is
not measured. It is calculated as the sum of the osmotic concentrations of sodium salts, urea,
and glucose in serum volume. The osmotic coefficient of sodium salts is usually taken to be
equal to 2.0 in these calculations. The error in the estimate of osmolarity from this calculation
is considered negligible. The total concentrations of osmotic substances in plasma, interstitial
fluid, and intracellular fluid are equal in the steady state [2].
Osmolality and tonicity of a solution, although related, are not the same. The total
concentration of dissolved solutes in a solution (the osmolality of this solution) determines its
colligative properties (the degree of lowering of the freezing point, elevation of the boiling
point, or depression of the vapor pressure from the corresponding value of pure
water). Osmolality is measured by instruments calibrated to express changes in a colligative
property (usually depression of the freezing point) in units of osmolality (mOsm/kg). The
osmolality of a solution represents the sum of the osmotic concentrations (the concentrations
times the corresponding osmotic coefficients) of all dissolved solutes. Tonicity of a solution is
the part of its total osmolality that can cause steady state osmotic water transfers between IC
and EC. The tonicity of a solution is evaluated by the photographic recording of rapid changes
in the volume of cells, usually red cells, suspended in this solution. This technology has been
applied only in research studies. Clinically, tonicity is estimated as the part of osmolarity
attributed to solutes with extracellular distribution (see below).
Gibbs-Donnan Equilibrium
The IC contains large molecular weight polyanions (e.g., proteins), to which the cell
membranes are, by and large, impermeable. Although its composition varies between tissues
and by distance from cell membranes, the fluid in the interstitial compartment, which is the
part of EC that is in direct contact with the cells, is considered to have negligible
concentrations of polyanions in general. Intracellular polyanions electrostatically attract
cations and repel anions across the cell membrane. The Gibbs-Donnan relationships express
the equilibrium status of electrolytes in a system of two compartments separated by a
semipermeable membrane when one of the compartments contains polyanions. Understanding
this equilibrium is required for analyzing water exchanges between the two compartments.
The Gibbs-Donnan equilibrium states that if there are impermeable anions in one of two
compartments separated by a semipermeable membrane: (a) the concentration of electrolyte
cations is higher and the concentration of electrolyte anions is lower in the compartment with
the impermeable anions; (b) the concentration of anions and cations is equal in the
compartment that does not contain impermeable anions; and (c) the products of the molar
concentrations (anions times cations) are equal in the two compartments. The mathematical
expression of the Gibbs-Donnan equilibrium between the EC and the interstitial compartment
is as follows:
{2}
{3}
{4}
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where [C]e and [A] e are the extracellular cation and anion electrolyte concentrations and [C] i
and [A]i the interstitial cation and anion electrolyte concentrations, respectively.
The Gibbs-Donnan equilibrium predicts that the sum of anions, plus cations, which is by far the
major constituent of osmolality of body fluids under normal conditions, is higher in the IC than
in the EC. This is a consequence of a geometric rule relevant to the Gibbs-Donnan
equilibrium. The rule states that the square has the smallest perimeter of all the rectangles that
have the same surface area. For example, a square with a 6 m side and a rectangle with sides of
4 and 9 m have the same surface area (6 × 6 = 4 × 9 m2). This relationship would fulfill the
requirements of equation 4. However, the perimeter of the square (4 × 6 = 24 m) is less than that
of the rectangle (2 × 4 + 2 × 9 = 26 m), and consequently, half of the perimeter of the square (2 x
6 = 12 m), which is an expression of equation 1, is less than that of the rectangle (4 + 9 = 13 m),
which is an expression of equation 3. As a consequence of this geometric rule, the sum of the
anions and cations (the osmolality) would be higher in the IC compartment than in the
interstitial compartment; consequently, an osmotic pressure difference favoring translocation
of interstitial fluid into the IC and cell swelling exists, creating the need for constant removal
of solute from the IC in order to maintain a constant cell volume. Maintenance of a constant
cell volume requires consumption of energy. Continuous sodium transfer outside the IC under
the influence of Na+-K+ ATPase is the main energy-consuming physiologic mechanism
protecting the volume of the cells. Cells swell under anoxic conditions or under the influence of
drugs inhibiting Na+-K+ ATPase [1].

Response of body cells to hypertonicity
Principles Governing the Distribution of Water Between the Major Body Compartments
The fundamental cell properties that are pertinent to the maintenance of cell volume in the
normal state and responsible for clinical abnormalities in cell volume during disturbances in
tonicity are the high permeability of cell membranes to water, which is universal with the
exception of the membranes of the cells in the cornea and, in the absence of vasopressin, of the
apical membranes of the principal cells in the renal medullary collecting ducts, and the
machinery to continuously expel cations from the cells (the Na+-K+ ATPase). Cell volume
abnormalities develop during disturbances of body water and solute balance and can be
quantitated by applying two principles that emanate from the high permeability of cell
membranes to water, the osmotic principle and the principle of body water distribution.
The osmotic principle states that in the steady state osmolality is the same in the IC and EC [3].
Experimental testing of the osmotic principle by measuring osmolality in serum and several
body tissues proved to be technically difficult and proof for this principle became available
approximately 15 years after Peters stated the principle [4-5].
The principle of body water distribution was formulated first [6], although it is a direct
consequence of the osmotic principle. This principle states that, in the steady state, body water
is distributed between the EC and the IC in proportion to the amount of solute in each
compartment [6]. Quantitative analyses of abnormalities in tonicity are routinely based on
the principle of body water distribution [7-14]. The formulas derived from these quantitative
analyses guide quantitative treatment prescriptions for clinical states of dystonicity. The
derivation, experimental testing, and limitations of these formulas should, therefore, be
understood.
General Mechanisms of Hypertonicity
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Rises in tonicity result from changes in body water, body solute, or both water and
solute. Combined gains or losses in water and solute generated through interactions between
the EC and the external environment are the more common sources of hypertonic
abnormalities. The loss in body water alone is seen in some clinical states (for example, in
diabetes insipidus). Hypertonicity caused by net solute gain without a change in body water is
uncommon. An example of this last hypertonic condition is hyperglycemia resulting from
excessive hepatic glucose production during insulin deficiency states occurring in anuric
subjects.
In terms of their ability to cause disturbances in tonicity, solutes are classified into two
categories, those that do and those that do not cause steady state changes in cell
volume. Increases in the body content of endogenous (e.g., urea) or exogenous (e.g., alcohols)
solutes distributed in total body water cause rises in body fluid osmolality but do not cause
changes in cell volume in the steady state. The clinical manifestations and treatment of
excesses in the body content of solutes with body water distribution are different from those of
hypertonicity [15-18]. Increases in the body content of solutes with EC distribution, whether
endogenous (glucose) or exogenous (salt, mannitol), cause hypertonicity [19-20]. If the solute
causing hypertonicity is not a sodium salt, the exit of water from the IC in hypertonic states
results in dilution of the EC sodium salts, which in the normal state are the main EC solutes
[19]. Tonicity is estimated as the sum of serum sodium concentration times its osmotic
coefficient, plus the osmotic concentration of glucose and/or any other solute with
extracellular distribution.
Most solute abnormalities leading to tonicity disturbances are accompanied by changes in body
water. Not taking into account the change in body water, regardless of how small it is, in the
calculations of fluid shifts between the IC and EC and of osmolality changes in disturbances of
tonicity can be the source of disproportionately large errors [8].
Mathematical Models of Hypertonicity
Traditionally, models of hypertonicity predicted the degree of increase in tonicity, gain in EC
volume, and loss in IC volume after a hypertonic disturbance of known volume and tonicity by
assuming that cells behave as perfect osmometers. Other gains or losses of water and solute,
principally through the urine, routinely interfere with the magnitude of the disturbances in
tonicity in clinical practice. These other gains or losses were not accounted for in the predictive
models [7-14]. Therefore, the existing mathematical models of hypertonicity are strictly
applicable only to anuric states.
Figure 1 shows the determinants of the changes in tonicity, body water, and body water
distribution in hypertonic states secondary to extracellular gains of hypertonic solutions in
anuria [11]. Table 1 explains the symbols for osmolalities and volumes in Figure 1.
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Ordinates Osmolalities (Os)

Abscissae Volumes (V,
V)

Ordinates Times Abscissae Solute
(mOsm)

Os1 = baseline

V e1 = baseline EC

Os1 x V e1 = baseline EC

Os2 = final

V i1 = baseline IC

Os1 x V i1= baseline IC

Os3 = infusate
Os4 = Hypothetical EC osmolality after equilibration of
osmolality in the EC but before any interactions between EC

V 1 = V e1 + V i1 =
baseline body water
V 3 = infusate (added) \
V = final EC gain

and IC

V +Ve1 = final EC

V – V3 = osmotic

Os3 x V 3 = infused

Os4 x (V e1 + V 3) = final EC

Os2 x (V e1 +

V) = final EC, Note:

Os4 x (V e1 + V 3) = Os2x(V e1 +
[Os] 2 x (V i1 – [

V – V3]) = final IC,

volume transfer from IC

Note: [Os]2 x (V i1 – [

to EC

Os1xV i1

V i1 – (

V)

V – V3]) =

V – V3) = final

IC

TABLE 1: Symbols Used in Figure 1.
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FIGURE 1: Stages of hypertonicity caused by extracellular gain
of a hypertonic solution.
Stage I: Addition of a hypertonic solution to the EC prior to any mixing between the EC and the
hypertonic solution. Stage II: Hypothetical stage of complete mixing of EC fluid and infused
hypertonic solution prior to any interaction with the IC. Stage IIII: Final steady state after
osmotic transfer of water from the IC into the EC that led to equal osmolalities in the two
compartments. Ordinates: volumes. Abscissae: osmolalities. The figure was constructed
assuming that Vi1 = 2xV e1, V3 = 0.5xV e1, and Os3 = 2xOs1. The numbers within the boxes show
osmolalities.

The necessary and sufficient conditions for cells to be considered as perfect osmometers are
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that total EC solute remains constant between stages II and III, total IC solute remains
constant between stages I, II, and III in Figure 1, and that equilibration of osmolalities between
the IC and EC is achieved exclusively by water transfer from the IC into the EC. Under these
conditions, the volumes Vi1 (baseline IC volume), Ve1 (baseline EC volume), V1 (baseline body
water or Vi1 + Ve1), and V 3 (volume of the infusate) and the osmolalities Os 1 (baseline
osmolality) and Os3 (osmolality of the infusate) are the independent variables, while the volume
V (the difference between the final and baseline EC volumes) and the final osmolality (Os 2)
are important dependent variables that can be calculated from the independent variables by the
following formulas [11].
Total EC volume expansion (\(\Delta\V) = osmotic shift of water from the IC into the EC, plus
volume infused):

{5}
For expansion with water (Os 3 = 0), equation 5 becomes:
{6}
For isotonic expansion (Os 3 = Os1 = Os2), equation 5 becomes:
{7}
Final osmolality:

{8}
If the infusate is hypertonic saline, equation 8 can be modified to calculate the final EC sodium
concentration as follows:

{9}
where [Na]3 = sodium concentration of the infusate, [Na] 1 = initial EC sodium concentration,
and [Na]2 = final EC sodium concentration (note: although rapidly exchangeable sodium is
distributed, by and large, in the EC, the changes in EC sodium concentration during
disturbances in tonicity are defined by total body water. This is a consequence of the osmotic
principle). Whether the large amount of sodium that is bound to polyanionic proteoglycans
primarily in cartilage, bone, and skin is available for rapid participation in tonicity disturbances
is not clear [21-22].
Formula 9 uses the same mathematical determinants of the change in serum sodium
concentration as the Adrogue-Madias formula, which is currently used to calculate the increase
in serum sodium concentration ([Na]2 – [Na] 1) after infusion of one liter of a saline solution
with a higher sodium concentration than the serum sodium concentration and is expressed by
the following relationship [10]:
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[10]
Formulas 9 and 10 provide essentially the same results [12].
If final osmolality (Os2) is known, the initial fluid volume that determines the final osmolality
(VOsm) after infusion of an amount of solute equal to Os3×V 3 is calculated by a modification of
the Fick equation that takes into account the volume infused as follows [11]:
{11}
Formula 11 calculates the so-called “osmotic volume of distribution”, which, under perfect
osmometer conditions, should be equal to the baseline body water (V 1) [7, 9]. If the EC
expansion is done with hypertonic saline, equation 10 can be modified to calculate the sodium
volume of distribution, as follows:
{12}
Under conditions of a perfect osmometer, V Na, VOsm, and V1 should be equal [7, 11]. Thus,
equations 11 and 12 allow the experimental estimation of body water. Comparison of body
water estimates obtained from equation 11 and simultaneous body water measurements
obtained by standard methods, such as isotopic water dilution, allowed testing of the
hypothesis that cells behave as perfect osmometers [7-9].
Experimental Testing of the Perfect Osmometer Hypothesis
Because the mathematical models of the perfect osmometer hypothesis ignored the renal
contribution to body fluid balance, experimental testing of its models and of metabolic
abnormalities that result from hypertonicity, such as acid-base disturbances and hyperkalemia,
has usually been carried out by infusion of hypertonic solutions into anephric or anuric animals
[7-8, 23-26]. In addition to hypertonicity, these experiments resulted in EC expansion by the
volume infused and the volume osmotically transferred from the IC. The results of these early
experiments are summarized below:
(a) The volume of the infused solution (V 3) has substantial effects on the results and must be
accounted for, even when it is small as it is in hypertonic infusions [8]. Equations 5-12
represent mathematically rigorous expressions of the perfect osmometer hypothesis because
they include all the determinants of changes in osmolality and body water distribution,
including the volume V3 [9, 12].
(b) In hypertonic saline expansion, the final serum sodium concentration is predicted
accurately by equation 9 and V Na estimated from equation 12 is equal to total body water
determined by reference methods. However, final osmolality is higher than the value predicted
by equation 8 and, consequently, VOsm is less than either body water or V Na [8, 26]. This finding
led to the conclusion that hypertonic expansion produces new solute, the so-called “idiogenic
osmoles” [8]. Hypotonic expansion experiments with water confirmed the finding that V Na is
equal to body water [27-28].
(c) Experimental testing of the perfect osmometer hypothesis was traditionally done by infusing
hypertonic solutions into acutely anuric or anephric experimental animals [7-8, 26]. In addition
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to hypertonicity, these experiments caused substantial extracellular expansion and progressive
azotemia, conditions leading to the generation of new solutes, not as a direct consequence of
hypertonicity. Extracellular expansion dilutes certain solutes, for example, glucose and
calcium, the extracellular concentration of which is tightly regulated by hormones. Rapid
responses of the regulatory hormones cause the release of these solutes in the extracellular
compartment from stores that were not osmotically active previously [26]. Similarly,
progressive azotemia indicates the progressive generation of new solute, primarily urea.
Correction for the new solute generated by extracellular expansion and azotemia accounted for
only part of the “idiogenic osmoles” [10]. Figure 2 shows the estimates of body water, V Na , and
VOsm calculated after infusion of hypertonic saline in one experimental study [26].

FIGURE 2: Estimates of body water and the osmotic and
sodium volume of distribution in acute hypernatremia.
Shown here are the average estimates of body water (VH2O) measured by tritiated water
dilution, the osmotic volume of distribution (VOsm) calculated by formula 11, and sodium
volume of distribution (VNa) calculated by formula 12 in a study of anuric dogs infused with
hypertonic saline [26]. The figure makes two points: (a) Even in acute hypertonicity, VOsm is
substantially lower than VH2O and (b) VNa is equal to VH2O. The equality of VNa and VH2O
provides the basis for applying equations 9 or 10 in the management of dysnatremias.

Although estimates of VNa and body water are remarkably similar under a variety of
experimental conditions, the discordance between V Osm and body water mandated the study of
“idiogenic osmoles”, which have, after their identification, been renamed “organic osmolytes”.
The Nature of “Idiogenic Osmoles”
The brain was identified early as an important site of deviation from perfect osmometric
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behavior in acute experimental hypertonicity. Hypertonic states reduce brain volume. However,
even in acute hypertonic states, the reduction in brain volume is substantially less than the
reduction predicted from calculations based on perfect osmometric behavior [29].
Astrocytes play a major role in the defense of brain volume in acute states of dystonicity
[30]. Immediate adaptation to brain shrinking includes movement of fluid from the
cerebrospinal fluid into the astrocytes. This is a limited adaptive mechanism. The main
adaptation occurs by a process called regulatory volume increase (RV), which consists of
intracellular solute gain.
The early component of RV in hypertonic states is accomplished within 30-120 minutes of the
hypertonic stimulus by the rapid influx of ions (sodium, chloride, and potassium) from the
interstitial compartment (which shrinks) into the brain IC [31-33]. In chronic hypertonicity,
which develops in days or weeks rather than minutes or hours, brain volume is restored by the
accumulation of organic compounds, the so-called “brain osmolytes” [34]. Figure 3 shows the
sequence of gains in brain osmolytes in acute and chronic hypertonicity [35-36].

FIGURE 3: Time course of brain organic osmolytes in
hypertonicity.
From experimental studies in rats subjected to acute and chronic hypernatremia [35] and from
the stage of correction of experimental chronic hyponatremia [36].

A number of major and minor organic osmolytes has been identified in the brain
[34]. Glutamate, glutamine, taurine, and myoinositol are considered as major osmolytes while
aspartate, alanine, glycine, choline, lysine, serine, threonine, glycerophosphorylcholine (GPC),
betaine, gamma-aminobutyric acid (GABA), and phosphocreatine are classified as minor
osmolytes [34]. Some of these osmolytes are amino acids acquired from the circulation while
others are polyols (myoinositol) or methylamines (betaine, GPC) formed locally. At least one
osmolyte (GABA) is a neurotransmitter. Organic osmolyte acquisition accounts for 30-50% of
the solute accumulation in the brain IC in chronic hypertonicity [34-35, 37-43] and is slow,
requiring two days or more to reach a steady state. Renal medulla is physiologically subjected
to rapid variations in interstitial tonicity and is endowed with a rapid mechanism of modifying
its intracellular osmolyte content. The main osmolytes in the renal medulla are sorbitol,
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myoinositol, GPC, and betaine [44].
Water administration in a state of acute hypertonicity leads to rapid loss of the excess
electrolytes and rapid restoration of the brain cell volume to normal. After correction of
chronic hypertonic states by water administration, organic osmolyte brain content declines
over two days [35].
Mechanisms of Intracellular Solute Gain in Hypertonicity
Hypertonicity causes activation of several ion transporters in cell membranes. Activation of the
Na+, K+, 2Cl- cotransporter leads to the intracellular transfer of sodium chloride and potassium
chloride. Tandem activation of Na+/H+ exchange and Cl-/HCO3- exchange leads also to sodium
chloride entry into the cells. Sodium ion entering the cells is extruded through Na+/K+ ATPase
in exchange for potassium. Potassium chloride is the final salt gained intracellularly in
hypertonicity [45].
The mechanisms responsible for the intracellular accumulation of organic osmolytes in
hypertonic states include intracellular formation and transport. Examples of solutes
acquired by intracellular formation include sorbitol formed from glucose under the catalytic
action of activated aldose reductase, GPC formed from phosphatidylcholine under the influence
of phospholipase A2, and amino acids derived from autophagic proteolysis. Examples of organic
osmolytes acquired by intracellular transport include myoinositol, betaine, and taurine, which
are acquired through the action of Na+ coupled transporters [45]. Hypertonicity activates a
variety of genes regulating metabolic functions and transporters responsible for the
intracellular accumulation of organic osmolytes [46]. Tonicity enhancer binding protein
(TonEBP) is a transcription factor found in abundance in the brain, renal medulla, heart, liver,
and activated T cells that plays a major role in hypertonicity and immune phenomena [47]. This
factor is activated by hypertonicity and regulates the expression of several osmolyte
transporters [47-48].
The alterations of metabolism induced by hypertonicity have dire consequences. Severe
hypertonicity leads to cell death by apoptosis. Apoptotic pathways activated by hypertonicity
include activation of caspase-8 and release of cytochrome 3 with activation of caspase-3 and
caspase-9 [49]. Elevated levels of the tumor suppressor p53, which initiates apoptotic pathways
in hypertonicity, is an important apoptotic mechanism activated by hypertonicity but
apparently not the only one [50].

Conclusions
Formulas used to calculate the volume of hypotonic solutions needed to correct the hypertonic
states do not take into account ongoing fluid losses during treatment, which should be
replaced. The same formulas also fail to account for the intracellular acquisition of new solute
created by the hypertonicity. This new solute is the source of serum osmolality values
substantially higher than those predicted by the formulas and may cause severe complications
during correction of the hypertonic states. When the hypertonic states are secondary to
conditions of known magnitude causing hypernatremia, the degree of observed elevation in the
serum sodium concentration is equal to the degree predicted by the formulas. This last
observation justifies the application of predictive formulas in the treatment of hypernatremia,
provided ongoing fluid losses are also addressed.
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